Keyword: Merck & Co.

News

US Drugmakers Urge Tax Code Reform

24.02.2017 - In a letter to the leadership of the US Congress, 16 CEOs of major American companies, including Pfizer’s Ian Read, Eli Lilly’s David Ricks, Merck & Co’s Ken Frazier and Celgene’s...

News

Trump Discusses Issues With Drugmakers

01.02.2017 - In a meeting at the White House on Jan. 31, new US president, Donald Trump, held out both a carrot and a stick to pharmaceutical producers. The industry will “have to “get prices...

News

Merck Settles Keytruda Patent Disputes

24.01.2017 - US drugmaker Merck has settled its patent dispute with rival Bristol-Myers Squibb (BMS) and Japan’s Ono Pharmaceutical over cancer immunotherapy Keytruda. Under terms of the...

News

Pharma Stocks Crash on Trump Pricing Hints

13.01.2017 - American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an...

News

US Firms Urge Trump to Uphold Paris Accord

12.01.2017 - More than 350 companies headquartered or with operations in the US, including such diverse enterprises as Monsanto, Genentech, Unilever, L’Oreal USA and the Merck Family Fund...

News

India’s Zydus Buys Brands from US Merck

03.01.2017 - Indian pharmaceutical company Zydus Cadila has acquired six brands from US drugmaker Merck for an undisclosed sum. The branded products are anabolic steroids Deca-Durabolin and...

News

Ebola Vaccine Trials Prove Efficacy

03.01.2017 - An experimental Ebola vaccine initially developed by the Public Health Agency of Canada and the US Army and eventually licensed to Merck, Sharp and Dohme, the international arm of...

News

Sanofi Files Patent Suit Against US Merck

20.09.2016 - French drugmaker Sanofi has filed a patent infringement suit in the United States District Court for the District of Delaware charging US pharmaceutical producer Merck with...